
RTT News
<img alt="" height="1" width="1" />
FDA OKs Amgen's bone drug in certain cancers
Reuters
LOS ANGELES, Nov 18 (Reuters) - The US Food and Drug Administration has approved Amgen Inc's (AMGN.O) bone drug denosumab as a treatment for reducing fractures and other bone problems in cancer patients with solid tumors, a spokeswoman ...
Amgen bone drug OK'd for use in cancer patientsBusinessWeek
Amgen's Bone Cancer Drug Xgeva Gets FDA ApprovalRTT News
Amgen's Bone Drug Denosumab Cleared to Treat Fractures in Cancer PatientsBloomberg
Pharmaceutical Business Review -Los Angeles Business Journal -Seattle Post Intelligencer
all 115 news articles »
More...